Logo image of AGFB.BR

AGFA-GEVAERT NV (AGFB.BR) Stock Fundamental Analysis

Europe - Euronext Brussels - EBR:AGFB - BE0003755692 - Common Stock

0.506 EUR
-0.02 (-2.88%)
Last: 1/16/2026, 7:00:00 PM
Fundamental Rating

3

Overall AGFB gets a fundamental rating of 3 out of 10. We evaluated AGFB against 11 industry peers in the Health Care Technology industry. While AGFB seems to be doing ok healthwise, there are quite some concerns on its profitability. AGFB has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year AGFB has reported negative net income.
  • In the past year AGFB had a positive cash flow from operations.
  • AGFB had negative earnings in 4 of the past 5 years.
  • AGFB had a negative operating cash flow in each of the past 5 years.
AGFB.BR Yearly Net Income VS EBIT VS OCF VS FCFAGFB.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

1.2 Ratios

  • AGFB's Return On Assets of -5.65% is on the low side compared to the rest of the industry. AGFB is outperformed by 70.00% of its industry peers.
  • Looking at the Return On Equity, with a value of -25.44%, AGFB is doing worse than 70.00% of the companies in the same industry.
Industry RankSector Rank
ROA -5.65%
ROE -25.44%
ROIC N/A
ROA(3y)-8.91%
ROA(5y)0.06%
ROE(3y)-32.3%
ROE(5y)1.63%
ROIC(3y)N/A
ROIC(5y)N/A
AGFB.BR Yearly ROA, ROE, ROICAGFB.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100

1.3 Margins

  • In the last couple of years the Operating Margin of AGFB has declined.
  • Looking at the Gross Margin, with a value of 29.77%, AGFB is doing worse than 80.00% of the companies in the same industry.
  • AGFB's Gross Margin has been stable in the last couple of years.
  • AGFB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.77%
OM growth 3Y-1.64%
OM growth 5Y-16.64%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.28%
GM growth 5Y0.88%
AGFB.BR Yearly Profit, Operating, Gross MarginsAGFB.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

4

2. Health

2.1 Basic Checks

  • AGFB does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, AGFB has about the same amount of shares outstanding.
  • AGFB has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, AGFB has a worse debt to assets ratio.
AGFB.BR Yearly Shares OutstandingAGFB.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
AGFB.BR Yearly Total Debt VS Total AssetsAGFB.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

  • An Altman-Z score of 2.30 indicates that AGFB is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • AGFB's Altman-Z score of 2.30 is in line compared to the rest of the industry. AGFB outperforms 60.00% of its industry peers.
  • AGFB has a debt to FCF ratio of 8.85. This is a slightly negative value and a sign of low solvency as AGFB would need 8.85 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 8.85, AGFB is doing worse than 60.00% of the companies in the same industry.
  • A Debt/Equity ratio of 0.57 indicates that AGFB is somewhat dependend on debt financing.
  • AGFB has a Debt to Equity ratio (0.57) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 8.85
Altman-Z 2.3
ROIC/WACCN/A
WACC9.77%
AGFB.BR Yearly LT Debt VS Equity VS FCFAGFB.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 2.02 indicates that AGFB has no problem at all paying its short term obligations.
  • With a decent Current ratio value of 2.02, AGFB is doing good in the industry, outperforming 70.00% of the companies in the same industry.
  • A Quick Ratio of 1.17 indicates that AGFB should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.17, AGFB is doing worse than 60.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.02
Quick Ratio 1.17
AGFB.BR Yearly Current Assets VS Current LiabilitesAGFB.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

3

3. Growth

3.1 Past

  • AGFB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -111.68%.
  • Looking at the last year, AGFB shows a decrease in Revenue. The Revenue has decreased by -1.87% in the last year.
  • AGFB shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -10.44% yearly.
EPS 1Y (TTM)-111.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
Revenue 1Y (TTM)-1.87%
Revenue growth 3Y-13.53%
Revenue growth 5Y-10.44%
Sales Q2Q%-7.22%

3.2 Future

  • AGFB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 32.19% yearly.
  • The Revenue is expected to grow by 0.57% on average over the next years.
EPS Next Y14.29%
EPS Next 2Y57.36%
EPS Next 3Y47.94%
EPS Next 5Y32.19%
Revenue Next Year-3.86%
Revenue Next 2Y-1.69%
Revenue Next 3Y-0.43%
Revenue Next 5Y0.57%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AGFB.BR Yearly Revenue VS EstimatesAGFB.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B 2.5B
AGFB.BR Yearly EPS VS EstimatesAGFB.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 0.4 -0.4 0.6

6

4. Valuation

4.1 Price/Earnings Ratio

  • AGFB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Based on the Price/Forward Earnings ratio of 9.92, the valuation of AGFB can be described as reasonable.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of AGFB indicates a rather cheap valuation: AGFB is cheaper than 90.00% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.29, AGFB is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 9.92
AGFB.BR Price Earnings VS Forward Price EarningsAGFB.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AGFB indicates a slightly more expensive valuation: AGFB is more expensive than 70.00% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, AGFB is valued cheaper than 90.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.92
EV/EBITDA 63.45
AGFB.BR Per share dataAGFB.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • AGFB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as AGFB's earnings are expected to grow with 47.94% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y57.36%
EPS Next 3Y47.94%

0

5. Dividend

5.1 Amount

  • AGFB does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

AGFA-GEVAERT NV

EBR:AGFB (1/16/2026, 7:00:00 PM)

0.506

-0.02 (-2.88%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-13
Earnings (Next)03-11
Inst Owners49.3%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap78.34M
Revenue(TTM)1.10B
Net Income(TTM)-73.00M
Analysts43.64
Price Target0.88 (73.91%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.36%
Min Revenue beat(2)-7.11%
Max Revenue beat(2)-1.61%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-27.77%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-1000%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.61%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 9.92
P/S 0.07
P/FCF 3.92
P/OCF 1.4
P/B 0.27
P/tB 1.45
EV/EBITDA 63.45
EPS(TTM)-0.46
EYN/A
EPS(NY)0.05
Fwd EY10.08%
FCF(TTM)0.13
FCFY25.53%
OCF(TTM)0.36
OCFY71.48%
SpS7.14
BVpS1.85
TBVpS0.35
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -5.65%
ROE -25.44%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 29.77%
FCFM 1.81%
ROA(3y)-8.91%
ROA(5y)0.06%
ROE(3y)-32.3%
ROE(5y)1.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-1.64%
OM growth 5Y-16.64%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.28%
GM growth 5Y0.88%
F-Score3
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 8.85
Debt/EBITDA 54.33
Cap/Depr 100%
Cap/Sales 3.26%
Interest Coverage N/A
Cash Conversion 1866.67%
Profit Quality N/A
Current Ratio 2.02
Quick Ratio 1.17
Altman-Z 2.3
F-Score3
WACC9.77%
ROIC/WACCN/A
Cap/Depr(3y)78.36%
Cap/Depr(5y)64.97%
Cap/Sales(3y)3.26%
Cap/Sales(5y)2.64%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-111.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
EPS Next Y14.29%
EPS Next 2Y57.36%
EPS Next 3Y47.94%
EPS Next 5Y32.19%
Revenue 1Y (TTM)-1.87%
Revenue growth 3Y-13.53%
Revenue growth 5Y-10.44%
Sales Q2Q%-7.22%
Revenue Next Year-3.86%
Revenue Next 2Y-1.69%
Revenue Next 3Y-0.43%
Revenue Next 5Y0.57%
EBIT growth 1Y-925%
EBIT growth 3Y-14.94%
EBIT growth 5Y-25.35%
EBIT Next Year134.7%
EBIT Next 3Y50.19%
EBIT Next 5Y43.36%
FCF growth 1Y119.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y181.16%
OCF growth 3YN/A
OCF growth 5YN/A

AGFA-GEVAERT NV / AGFB.BR FAQ

Can you provide the ChartMill fundamental rating for AGFA-GEVAERT NV?

ChartMill assigns a fundamental rating of 3 / 10 to AGFB.BR.


What is the valuation status for AGFB stock?

ChartMill assigns a valuation rating of 6 / 10 to AGFA-GEVAERT NV (AGFB.BR). This can be considered as Fairly Valued.


How profitable is AGFA-GEVAERT NV (AGFB.BR) stock?

AGFA-GEVAERT NV (AGFB.BR) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for AGFB stock?

The Earnings per Share (EPS) of AGFA-GEVAERT NV (AGFB.BR) is expected to grow by 14.29% in the next year.


Is the dividend of AGFA-GEVAERT NV sustainable?

The dividend rating of AGFA-GEVAERT NV (AGFB.BR) is 0 / 10 and the dividend payout ratio is 0%.